|
|
||||||||
Commissariat à l'Energié Atomique, Service Hospitalier Frédéric Joliot F-91406, Orsay, France
Correspondence: For reprint contact: C. Loc'h, Commissariat a l'Energie Atomique, Dept. de Biologie, Service Hospitalier Frédéric Joliot, F-91406 Orsay France.
ABSTRACT
To meet the needs created by the rapid development of positron tomographic techniques,a new Ge-68
Ga-68 generator has been developed. By elution under reduced pressure, this tin dioxide/1 N HCI generator provides a sterile solution of Ga-68 in ionic form, ready for use in the preparation of many radiopharmaceuticals. Since the Ga-68 recovery yield is high (7580%) and the elution time very short (less than 2 min), these products possess maximum activity. Owing to its very slight Ge-68 leakage (<0.0002% per elution), the tin dioxide/HCI generator is long-lasting and, more importantly, the radiotoxicity of the labeled derivatives is kept to a minimum. The ionic Ga-68 obtained in this way has been used to label several radiopharmaceuticals.
This article has been cited by other articles:
![]() |
G. L. Griffiths, C.-H. Chang, W. J. McBride, E. A. Rossi, A. Sheerin, G. R. Tejada, H. Karacay, R. M. Sharkey, I. D. Horak, H. J. Hansen, et al. Reagents and Methods for PET Using Bispecific Antibody Pretargeting and 68Ga-Radiolabeled Bivalent Hapten-Peptide-Chelate Conjugates J. Nucl. Med., January 1, 2004; 45(1): 30 - 39. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |